Relating To Registration To Sell Manufactured Hemp Products.
SB1430 creates a new registration system for manufactured hemp product distributors and retailers in Hawaii. Beginning January 1, 2026, these sellers would be prohibited from selling or offering manufactured hemp products unless they obtain a certificate of registration from the Department of Health, pay a $50 application fee, renew annually for $50, and display the certificate at their place of business and, if selling online, on their website. The bill also requires the department to maintain a public registry of registrants and authorizes inspections, sampling, testing, and record review at registered locations.
The measure defines key terms such as manufactured hemp product retailer, distributor, consumer, registrant, registry, and sale, and it clarifies that carriers shipping goods are not regulated merely for transporting hemp products. It also expands enforcement provisions so the department may suspend or revoke a certificate of registration for noncompliance and may seek judicial enforcement of penalties. Finally, it updates the Hawaii hemp processing special fund to support both hemp processor permitting and the new registration program for manufactured hemp product sellers.
SB1430 would amend Chapter 328G, Hawaii Revised Statutes, by adding a new regulatory framework for manufactured hemp product retailers and distributors and by conforming related definitions and enforcement provisions. It would give the Department of Health new authority to register sellers, collect fees, publish a registry, inspect facilities and records, and suspend or revoke registrations for violations. The bill would also direct hemp processing special fund moneys toward administering the new registration system, affecting hemp businesses, online sellers, distributors, and consumers of hemp-derived cannabinoid products.
Based on the bill findings and the absence of recorded opposition or committee testimony in the provided materials, the overall sentiment appears supportive and precautionary. The bill is framed as a consumer-protection and enforcement measure intended to address non-compliant hemp-derived cannabinoid products, improve traceability, and help the Department of Health respond to health risks. No votes or committee discussion are included, so there is no documented public debate in the provided record.
The main policy tension is between consumer safety and regulatory burden. Supporters, as reflected in the bill text, emphasize that many hemp-derived cannabinoid products sold in Hawaii are imported or otherwise non-compliant and that a registration system is needed to identify sellers and trace adverse events. Potential points of contention include the new $50 application and renewal fees, the inspection and record-access authority granted to the department, the requirement that online sellers display certificates publicly, and the possibility of suspension or revocation for noncompliance. The bill also narrows the scope of who is covered by excluding carriers unless they themselves sell hemp products.